Atlas Trials

A Bioequivalence Study Using Clinical Endpoint for Diclofenac Sodium Gel 1% in Osteoarthritis Knee"

Clinical trial NCT03172780 · COMPLETED

Trial details

NCT number
NCT03172780
Sponsor
Mylan Pharmaceuticals Private Limited
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Osteoarthritis, Knee
Start date
2017-05-24
Primary completion
2017-12-05
Enrollment
1220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.